• HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

  • Apr 21 2025
  • Length: 1 hr and 40 mins
  • Podcast

HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

  • Summary

  • Clinical investigators discuss available data guiding the management of HER2-positive, triple-negative and localized breast cancer. 

    CME information and select publications here.

    Show more Show less
adbl_web_global_use_to_activate_webcro768_stickypopup

What listeners say about HER2-Positive and Triple-Negative Breast Cancer — Fourth Annual National General Medical Oncology Summit

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.